Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 122.18%146.93M | ---- | 141.13%66.13M | ---- | 44.66%-160.8M | ---- | 46.34%-290.58M | ---- | 20.31%-541.56M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 20.55%-234.08M | ---- | 18.98%-294.65M | ---- | 14.90%-363.69M | ---- | 22.50%-427.37M | ---- | 31.01%-551.47M | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -156.14%-146K | ---- |
| Impairment and provisions: | -72.82%43.21M | ---- | -62.10%158.93M | ---- | -28.93%419.39M | ---- | -37.73%590.1M | ---- | -28.60%947.71M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.83M | ---- |
| -Other impairments and provisions | -72.82%43.21M | ---- | -62.10%158.93M | ---- | -28.93%419.39M | ---- | -37.55%590.1M | ---- | -28.81%944.88M | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | --111K | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | --111K | ---- | ---- | ---- |
| Depreciation and amortization: | -11.68%4.8M | ---- | -36.18%5.44M | ---- | -39.07%8.52M | ---- | 3.16%13.98M | ---- | -7.65%13.55M | ---- |
| -Depreciation | 4.03%3.02M | ---- | -24.22%2.9M | ---- | 23.25%3.83M | ---- | 12.54%3.11M | ---- | 0.11%2.76M | ---- |
| Financial expense | -85.02%525K | ---- | -76.44%3.5M | ---- | -44.60%14.87M | ---- | -62.46%26.85M | ---- | -35.22%71.52M | ---- |
| Special items | 27,972.41%16.17M | ---- | -222.22%-58K | ---- | ---18K | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | 63.00%-22.46M | ---- | 25.72%-60.7M | ---- | 5.97%-81.72M | ---- | -43.91%-86.91M | ---- | -127.04%-60.39M | ---- |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | 124.57%47.21M | ---- | -687.71%-192.16M | ---- | -102.94%-24.39M | ---- | -63.69%830.1M | ---- | 220.65%2.29B | ---- |
| Accounts payable increase (decrease) | 48.61%346.57M | ---- | 302.65%233.2M | ---- | 67.89%-115.07M | ---- | -217.34%-358.38M | ---- | 119.83%305.41M | ---- |
| Special items for working capital changes | 65.12%388.46M | ---- | -13.19%235.26M | ---- | 196.66%271.01M | ---- | -307.06%-280.36M | ---- | 123.62%135.41M | ---- |
| Cash from business operations | 252.41%759.78M | ---- | 332.75%215.6M | ---- | -52.30%49.82M | ---- | -96.08%104.45M | ---- | 213.20%2.67B | ---- |
| Hong Kong profits tax paid | 269.99%8.33M | ---- | -484.16%-4.9M | ---- | 105.22%1.28M | ---- | -133.75%-24.44M | ---- | 54.17%-10.46M | ---- |
| China income tax paid | -53.33%-23K | ---- | 11.76%-15K | ---- | 10.53%-17K | ---- | 50.00%-19K | ---- | 65.14%-38K | ---- |
| Other taxs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18K | ---- |
| Interest received - operating | -14.40%234.69M | ---- | -19.11%274.16M | ---- | -15.83%338.91M | ---- | -22.62%402.65M | ---- | -34.12%520.35M | ---- |
| Interest paid - operating | 85.67%-507K | ---- | 75.25%-3.54M | ---- | -26.44%-14.3M | ---- | 31.49%-11.31M | ---- | -26.03%-16.5M | ---- |
| Special items of business | ---- | 164.71%556.65M | ---- | 145.23%210.29M | ---- | -50.59%85.75M | ---- | -93.97%173.53M | ---- | 239.04%2.88B |
| Net cash from operations | 108.24%1B | 164.71%556.65M | 28.11%481.3M | 145.23%210.29M | -20.29%375.7M | -50.59%85.75M | -85.09%471.33M | -93.97%173.53M | 297.26%3.16B | 239.04%2.88B |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | -76.92%6K | ---- | --26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | 90.62%-387K | ---- | -20.16%-4.12M | ---- | 55.38%-3.43M | ---- | -2,707.30%-7.69M | ---- | 74.49%-274K | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --3.53M | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---604K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | 99.87%-7K | ---- | -143.13%-5.51M | ---- | -50.30%-2.27M | ---- | -836.02%-1.51M | ---- | -114.38%-161K |
| Net cash from investment operations | 75.96%-985K | 99.87%-7K | -19.41%-4.1M | -143.13%-5.51M | 17.60%-3.43M | -50.30%-2.27M | -1,420.07%-4.17M | -836.02%-1.51M | 74.49%-274K | -114.38%-161K |
| Net cash before financing | 109.82%1B | 171.83%556.65M | 28.19%477.21M | 145.29%204.78M | -20.31%372.26M | -51.47%83.48M | -85.22%467.17M | -94.02%172.03M | 297.11%3.16B | 238.57%2.88B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | -73.83%840M | ---- | -40.11%3.21B | ---- | 54.47%5.36B | ---- | -89.94%3.47B | ---- |
| Refund | ---- | ---- | 69.39%-1.05B | ---- | 35.28%-3.43B | ---- | 3.13%-5.3B | ---- | 83.09%-5.47B | ---- |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | 74.85%-19.04M | ---- | 49.66%-75.69M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | 44.44%-500M | ---- | 36.98%-899.87M | ---- |
| Other items of the financing business | ---- | 97.84%-4.64M | ---- | -79.44%-215.32M | ---- | 21.19%-120M | ---- | 93.67%-152.26M | ---- | -84.38%-2.4B |
| Net cash from financing operations | 96.25%-8.21M | 97.84%-4.64M | 5.24%-218.69M | -79.44%-215.32M | 50.94%-230.8M | 21.19%-120M | 84.26%-470.43M | 93.67%-152.26M | -643.63%-2.99B | -84.38%-2.4B |
| Net Cash | 284.14%993.07M | 5,334.27%552.01M | 82.74%258.52M | 71.12%-10.55M | 4,431.51%141.47M | -284.79%-36.52M | -101.90%-3.27M | -95.82%19.76M | 116.33%172.03M | 204.05%472.58M |
| Begining period cash | 25.79%1.26B | 25.79%1.26B | 16.43%1B | 16.43%1B | -0.38%860.8M | -0.38%860.8M | 24.86%864.06M | 24.86%864.06M | -60.35%692.03M | -60.35%692.03M |
| Cash at the end | 78.77%2.25B | 82.79%1.81B | 25.79%1.26B | 20.31%991.72M | 16.43%1B | -6.74%824.28M | -0.38%860.8M | -24.11%883.82M | 24.86%864.06M | -9.81%1.16B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.